These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25232267)

  • 1. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.
    Li LF; Wei ZJ; Sun H; Jiang B
    World J Gastroenterol; 2014 Sep; 20(34):12313-21. PubMed ID: 25232267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important.
    Yang Y; Shen J; He J; He J; Jiang G
    Clin Transl Oncol; 2016 Jul; 18(7):685-92. PubMed ID: 26459256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.
    Lin S; Ma R; Zheng XY; Yu H; Liang X; Lin H; Cai XJ
    World J Gastroenterol; 2014 Jan; 20(4):1107-13. PubMed ID: 24574785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis.
    Yin S; Chen FF; Yang GF
    Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
    Zhang CT; He KC; Pan F; Li Y; Wu J
    World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
    Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
    Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
    Cheng H; Wang X; Li T; Chen L
    Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot research for the correlation between the expression pattern of E-cadherin-β-catenin complex and lymph node metastasis in early gastric cancer.
    Yoshii T; Miyagi Y; Nakamura Y; Kobayashi O; Kameda Y; Ohkawa S
    Tumori; 2013; 99(2):234-8. PubMed ID: 23748820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of E-cadherin correlates with poor prognosis and unfavorable clinicopathological features in gastric carcinoma: a meta-analysis.
    Lu G; Cai Z; Jiang R; Tong F; Tu J; Chen Y; Fu Y; Sun J; Zhang T
    Aging (Albany NY); 2024 Jun; 16(12):10271-10298. PubMed ID: 38870263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
    Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
    BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
    Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
    Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.
    Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH
    BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
    Hu L; Luo H; Wang W; Li H; He T
    PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.